TRPV1 and cervical carcinoma: The anti-proliferative effect of NaHS was rescued by preventing TRPV1-induced extracellular Ca2+ entry wither with capsazepine or KB-R 7943, as recently reported in leukemia, breast cancer, cervical carcinoma cell lines [41].